ChiCTR2500112415 版本V1.0 版本创建时间2025/11/13 16:43:51 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500112415 

最近更新日期:

Date of Last Refreshed on:

2025-11-13 16:43:30 

注册时间:

Date of Registration:

2025-11-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

改良膨宫连接方法对宫腔镜手术的临床应用效果分析

Public title:

Clinical Analysis of the Modified Balloon-Expansion Connection Technique in Hysteroscopic Surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

改良蠕动式膨宫泵连接方法对宫腔镜手术的临床应用效果分析

Scientific title:

Clinical Efficacy Analysis of a Modified Peristaltic Hysteroscopic Distension Pump Connection Method in Hysteroscopic Surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

程世萍 

研究负责人:

程世萍 

Applicant:

Shiping Cheng 

Study leader:

Shiping Cheng 

申请注册联系人电话:

Applicant telephone:

+86 21 6407 0434

研究负责人电话:

Study leader's telephone:

+86 21 6407 0434

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1310370267@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1310370267@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区衡山路910号

研究负责人通讯地址:

上海市徐汇区衡山路910号

Applicant address:

910 Hengshan Road, Xuhui District, Shanghai, China

Study leader's address:

910 Hengshan Road, Xuhui District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国福利会国际和平妇幼保健院

Applicant's institution:

China Welfare Foundation International Peace Maternity and Child Health Hospital

研究负责人所在单位:

中国福利会国际和平妇幼保健院

Affiliation of the Leader:

The international peace maternity and child health hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

GKLW-A-2025-048-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国福利会国际和平妇幼保健院医学科研伦理委员会

Name of the ethic committee:

Medical Research Ethics Committee International Peace Maternal and Child Health Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-06-07 00:00:00

伦理委员会联系人:

张延菲

Contact Name of the ethic committee:

Zhang YanFei

伦理委员会联系地址:

上海市徐汇区衡山路910号

Contact Address of the ethic committee:

910 Hengshan Road, Xuhui District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 64070434

伦理委员会联系人邮箱:

Contact email of the ethic committee:

jxzhangyanfei@163.com

研究实施负责(组长)单位:

中国福利会国际和平妇幼保健院

Primary sponsor:

The international peace maternity and child health hospital

研究实施负责(组长)单位地址:

上海市徐汇区衡山路910号

Primary sponsor's address:

910 Hengshan Road, Xuhui District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

中国福利会国际和平妇幼保健院

具体地址:

上海市徐汇区衡山路910号

Institution
hospital:

The international peace maternity and child health hospital

Address:

910 Hengshan Road, Xuhui District, Shanghai, China

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-selected topic

Target disease:

Patients scheduled for hysteroscopic procedures in the operating theatre for uterine cavity disorders

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

验证膨宫泵改良连接方法对宫腔镜手术膨宫压力稳定性和术野清晰度的提升效果,并评估其缩短手术时间、减少灌流介质负欠量的作用。分析膨宫泵改良方法对医疗成本、人力成本及安全性的影响。  

Objectives of Study:

To validate the efficacy of the modified connection method for the insufflation pump in enhancing pressure stability and surgical field visibility during pneumoperitoneum, whilst assessing its role in reducing operative time and minimising negative perfusion medium deficits. To analyse the impact of the modified insufflation pump method on healthcare costs, staffing requirements, and patient safety.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.择期行宫腔镜手术的患者;
2.年龄18~65岁;
3.BMI 18~30 kg/m2;

Inclusion criteria

1.Patients scheduled for elective hysteroscopic surgery;
2.Age: 18 to 65 years old;
3.Body Mass Index (BMI) 18–30 kg/m2;

排除标准:

1.①糖尿病患者;
2.②绝育手术史患者;
3.③子宫恶性病变患者;
4.④急性盆腔炎或慢性盆腔炎急性发作患者;

Exclusion criteria:

1.① Patients with diabetes mellitus;
2.② Patients with a history of sterilisation surgery;
3.③ Patients with malignant uterine lesions;
4.④ Patients with acute pelvic inflammatory disease or acute exacerbation of chronic pelvic inflammatory disease;

研究实施时间:

Study execute time:

From 2025-11-01 00:00:00 To 2026-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-11-15 00:00:00 To 2025-11-30 00:00:00  

干预措施:

Interventions:

组别:

对照组(传统连接法)

样本量:

30

Group:

Control group (conventional connection method)

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

组别:

观察组(改良连接法)

样本量:

30

Group:

Observation group (modified connection method)

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China 

Province:

Shanghai 

City:

 

单位(医院):

中国福利会国际和平妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

The international peace maternity and child health hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

宫腔镜检查时间(分钟)

指标类型:

主要指标

Outcome:

Hysteroscopic examination duration (minutes)

Type:

Primary indicator

测量时间点:

测量方法:

记录宫腔镜进入子宫宫腔后看见双侧宫角所需要的时间

Measure time point of outcome:

Measure method:

The time required to observe both uterine horns following hysteroscopic entry into the uterine cavity.

指标中文名:

手术时间(分钟)

指标类型:

主要指标

Outcome:

Duration of surgery (minutes)

Type:

Primary indicator

测量时间点:

测量方法:

记录从宫腔镜进入子宫宫腔,手术开始到手术结束宫腔镜退出子宫宫腔,总共需要多长时间。

Measure time point of outcome:

Measure method:

Record the total duration from the hysteroscope entering the uterine cavity at the commencement of the procedure until its withdrawal from the uterine cavity at the conclusion of the procedure.

指标中文名:

灌流介质负欠量(ml)

指标类型:

主要指标

Outcome:

Negative deficit in perfusion medium (ml)

Type:

Primary indicator

测量时间点:

测量方法:

灌流介质负欠量=术中使用的灌流介质总量-灌流介质流出量

Measure time point of outcome:

Measure method:

Negative deficit of perfusion medium = Total volume of perfusion medium used during surgery - Volume of perfusion medium drained

指标中文名:

医生对术野清晰度评分(5分制评分)

指标类型:

主要指标

Outcome:

Surgeon's assessment of surgical field clarity (5-point scale)

Type:

Primary indicator

测量时间点:

测量方法:

自制5分制评分表(极清晰5分,清晰4分,较清晰3分,模糊2分,极模糊1分),给予手术医生根据实际手术视野清晰度打分。

Measure time point of outcome:

Measure method:

Self-made 5-point rating scale (Extremely clear: 5 points, Clear: 4 points, Fairly clear: 3 points, Blurred: 2 points, Extremely blurred: 1 point), to be completed by the operating surgeon based on the actual clarity of the surgical field.

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

可联系通讯作者邮箱

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Please contact the corresponding author via email.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子表单

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-11-13 16:43:30